Health Policy RegulationPolicy Issue

Compounding injected drugs without safety or efficacy data

April 1, 2026Eric Topol

Eric Topol warns FDA may lift a ban under political pressure, calling it an unprecedented red line because it would allow compounding drugs injected into the bloodstream without safety or efficacy data.

If FDA does this, which is highly likely succumbing to pressure from RFK Jr, it crosses a new red line and, as far as I know, is unprecedented.
Lifting a ban on drugs that are injected into the bloodstream without data for safety or efficacy, so they can be compounded
Eric Topol
FDAcompoundingdrug safety

See what experts are saying right now

This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.

← Back to Healthcare